SOURCES SOUGHT
A -- Assessment of Potential Cocaine Treatment Medications
- Notice Date
- 4/3/2012
- Notice Type
- Sources Sought
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211 - MSC 9559, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- N01DA-13-8908
- Archive Date
- 5/5/2012
- Point of Contact
- Lisa V. Bielen, Phone: 301.443.6677
- E-Mail Address
-
lisa.bielen@nih.gov
(lisa.bielen@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- The purpose of this research and development contract is the preclinical evaluation of test compounds as potential pharmacotherapies for substance abuse. To this end, the offeror and technical personnel need to have the capability and experience to conduct experiments evaluating compounds in the mouse locomotor activity, rat drug discrimination, rat conditioned place preference, mouse stress-induced potentiation of conditioned place preference, and rat self-administration paradigms. The offeror and technical staff also need to have experience conducting these types of experiments using cocaine, methamphetamine, nicotine, THC, and hallucinogens. Evidence of experience must be documented through publications using the relevant behavioral models listed above. In addition, the offeror needs to have the dedicated laboratory space, animal care facilities, and equipment required to conduct these behavioral assays. Proprietary compounds will be evaluated using established protocols, and the resulting data will be utilized by the Addiction Treatment Discovery Program of the NIDA Division of Pharmacotherapies and Medical Consequences of Drug Abuse. The successful offeror must submit documentation of a current DEA registration for Schedules II - IV controlled substances and the eligibility to obtain Schedule I prior to award. All offerors must be in compliance with the NIH guidelines on the care and use of laboratory animals. Offerors should demonstrate capability to administer and coordinate interrelated tasks in an effective and timely manner.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/N01DA-13-8908/listing.html)
- Record
- SN02712992-W 20120405/120403235945-5cdc25e7570ddfce900cf7a29c8c33d9 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |